Target
Glutamate carboxypeptidase 2
Ligand
BDBM50089452
Substrate
n/a
Meas. Tech.
ChEMBL_1497035 (CHEMBL3579845)
Ki
0.008600±n/a nM
Citation
 Tykvart, JSchimer, JJancarík, ABarinková, JNavrátil, VStarková, J?rámková, KKonvalinka, JMajer, P?ácha, P Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II. J Med Chem 58:4357-63 (2015) [PubMed]  Article
Target
Name:
Glutamate carboxypeptidase 2
Synonyms:
FGCP | FOLH | FOLH1 | FOLH1_HUMAN | Folate hydrolase 1 | Folylpoly-gamma-glutamate carboxypeptidase | Glutamate carboxypeptidase 2 | Glutamate carboxypeptidase II | Membrane glutamate carboxypeptidase | N-acetylated-alpha-linked acidic dipeptidase I | NAALAD1 | NAALADase I | PSM | PSMA | Prostate-specific membrane antigen | Pteroylpoly-gamma-glutamate carboxypeptidase | mGCP
Type:
PROTEIN
Mol. Mass.:
84333.66
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1497035
Residue:
750
Sequence:
MWNLLHETDSAVATARRPRWLCAGALVLAGGFFLLGFLFGWFIKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA
  
Inhibitor
Name:
BDBM50089452
Synonyms:
CHEMBL3578201
Type:
Small organic molecule
Emp. Form.:
C60H59BrN8O14
Mol. Mass.:
1196.06
SMILES:
OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCN(Cc1ccc(Br)cc1)C(=O)c1ccc(nc1)N1CCN(CC1)c1ccc(cc1)N1CCN(CC1)C(=O)c1ccc(C(O)=O)c(c1)-c1c2ccc(O)cc2oc2cc(=O)ccc12)C(O)=O)C(O)=O |r,wU:5.5,wD:10.9,(14.8,28.06,;14.79,26.82,;15.85,26.2,;13.45,26.06,;12.12,26.84,;10.78,26.08,;9.45,26.86,;8.11,26.1,;8.1,24.87,;6.78,26.88,;5.44,26.12,;4.11,26.9,;2.77,26.14,;1.44,26.92,;.1,26.16,;-1.22,26.94,;-1.21,28.49,;.13,29.24,;.15,30.78,;1.49,31.54,;2.82,30.75,;3.89,31.36,;2.8,29.21,;1.46,28.46,;-2.57,26.19,;-3.63,26.81,;-2.58,24.65,;-3.92,23.89,;-3.93,22.35,;-2.6,21.57,;-1.26,22.33,;-1.25,23.87,;-2.61,20.02,;-3.95,19.26,;-3.96,17.72,;-2.63,16.94,;-1.29,17.71,;-1.28,19.25,;-2.64,15.4,;-3.97,14.64,;-3.98,13.1,;-2.65,12.32,;-1.31,13.09,;-1.31,14.63,;-2.65,10.78,;-3.99,10.02,;-3.99,8.48,;-2.66,7.7,;-1.33,8.47,;-1.32,10.01,;-2.66,6.16,;-3.73,5.55,;-1.33,5.39,;0,6.16,;1.34,5.39,;1.34,3.85,;2.67,3.09,;2.68,2.06,;3.74,3.7,;0,3.08,;-1.33,3.85,;,1.54,;1.31,.77,;2.67,1.54,;4,.77,;4,-.77,;5.07,-1.39,;2.67,-1.54,;1.31,-.77,;,-1.54,;-1.33,-.77,;-2.67,-1.54,;-4,-.77,;-5.07,-1.39,;-4,.77,;-2.67,1.54,;-1.33,.77,;5.43,24.58,;4.36,23.97,;6.5,23.96,;10.77,24.54,;11.83,23.92,;9.69,23.94,)|
Structure:
Search PDB for entries with ligand similarity: